ANTABIO
Live / Registered — Registered — Section 71 accepted (as of 28 Mar 2026)
What this means for you
Registered since 26 Nov 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79249182
- Registration number
- 5917268
- Mark type
- Stylized text
- Filed
- 20 Jul 2018
- Published for opposition
- 10 Sept 2019
- Registered
- 26 Nov 2019
- Attorney of record
- Gregory J. Chinlund
Goods and services
- Class 001 — Chemicals: Chemical preparations for use in the production of drugs; [ chemical reagents other than for medical or pharmaceutical purposes; bacterial preparations other than for medical purposes; bacteriological preparations other than for medical purposes; ] chemical preparations for scientific purposes other than for medical purposes [ ; cultures of micro-organisms other than for medical purposes; biological tissue cultures other than for medical purposes; diagnostic preparations other than for medical purposes ]
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of [ viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, ] respiratory [ , neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system ] related diseases, infections and disorders; drugs for human use for the treatment of [ viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, ] respiratory [ , neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases, ] infections and disorders; [ chemicals, namely, enzymes for use in pharmaceutical preparations; ] medical or pharmaceutical preparations, particularly for the diagnosis and treatment of life-threatening and drug-resistant bacterial infections; [ hygienic preparations for medicine, namely, disinfectants; ] chemical preparations for medical or pharmaceutical purposes, especially for the diagnosis and treatment of life-threatening and drug-resistant bacterial infections [ ; bacterial preparations for medical or pharmaceutical purposes; bacteriological preparations for medical or pharmaceutical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; preparations of micro-organisms, namely, cultures of microorganisms for medical or pharmaceutical purposes; chemical reagents for medical or pharmaceutical purposes; biomarker reagents for diagnostics for medical purposes; Pharmaceuticals and natural remedies, being medicines for human purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases, infections and disorders ]
- Class 042 — Scientific and technological services: Scientific research, development [ and design services ] in the pharmaceutical [ , biological and clinical ] field; [ biological research; chemistry research; bacteriology research; laboratory testing, namely, bacteriological testing; conducting clinical trials for others; ] quality evaluation, analysis and research in the fields of science and technology made by engineers and researchers; technical project studies, namely, technical research in the field of bacterial infections and diseases [ ; scientific information, advisory and consultancy services relating to the aforesaid ]
Owner
- Antabio SAS, Labège, FR
- Antabio SAS, FR
- Antabio SAS, FR
Prosecution history
- 28 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 28 Mar 2026 — REGISTERED-SEC.71 ACCEPTED
- 23 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Nov 2025 — TEAS SECTION 71 RECEIVED
- 26 Nov 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 06 Nov 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 03 Apr 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 17 Mar 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 17 Mar 2020 — FINAL DISPOSITION PROCESSED
- 26 Feb 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 26 Nov 2019 — REGISTERED-PRINCIPAL REGISTER
- 25 Oct 2019 — NEW REPRESENTATIVE AT IB RECEIVED
- 10 Sept 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Sept 2019 — PUBLISHED FOR OPPOSITION
- 21 Aug 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED